ArticleCancer immunology, immunotherapy : CII2023

Generation of NK cells with chimeric-switch receptors to overcome PD1-mediated inhibition in cancer immunotherapy.

Katharina H Susek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.